Structure Therapeutics Inc. Increase Decrease In Operating Lease Liability
Structure Therapeutics Inc. (GPCR) reported Increase Decrease In Operating Lease Liability of -$1.46 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-06
- Structure Therapeutics Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$763.00K.
- Structure Therapeutics Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$695.00K.
- Structure Therapeutics Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$603.00K.
- Structure Therapeutics Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$601.00K.
- Structure Therapeutics Inc. increase decrease in operating lease liability for fiscal 2025 was -$2.30M.
- Structure Therapeutics Inc. increase decrease in operating lease liability for fiscal 2024 was -$1.59M.
- Structure Therapeutics Inc. increase decrease in operating lease liability for fiscal 2023 was -$315.00K.
- Structure Therapeutics Inc. increase decrease in operating lease liability for fiscal 2022 was -$361.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$763.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.46M 10-Q · filed 2026-08-06 | -$2.06M derived: sum of 3 quarters · filed 2026-08-06 | -$2.66M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$695.00K 10-Q · filed 2026-05-07 | -$1.30M derived: sum of 2 quarters · filed 2026-05-07 | -$1.90M derived: sum of 3 quarters · filed 2026-05-07 | -$2.53M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$603.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.20M derived: sum of 2 quarters · filed 2026-02-26 | -$1.84M derived: sum of 3 quarters · filed 2026-08-06 | -$2.30M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$601.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.23M derived: sum of 2 quarters · filed 2026-08-06 | -$1.69M 10-Q · filed 2025-11-06 | -$2.22M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$633.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.09M 10-Q · filed 2026-08-06 | -$1.61M derived: sum of 3 quarters · filed 2026-08-06 | -$1.90M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$459.00K 10-Q · filed 2026-05-07 | -$982.00K derived: sum of 2 quarters · filed 2026-05-07 | -$1.27M derived: sum of 3 quarters · filed 2026-05-07 | -$1.72M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$523.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$812.00K derived: sum of 2 quarters · filed 2026-02-26 | -$1.26M derived: sum of 3 quarters · filed 2026-02-26 | -$1.59M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$289.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$740.00K derived: sum of 2 quarters · filed 2025-11-06 | -$1.07M 10-Q · filed 2025-11-06 | -$1.14M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$451.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$779.00K 10-Q · filed 2025-08-06 | -$850.00K derived: sum of 3 quarters · filed 2026-02-26 | -$907.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$328.00K 10-Q · filed 2025-05-08 | -$399.00K derived: sum of 2 quarters · filed 2026-02-26 | -$456.00K derived: sum of 3 quarters · filed 2026-02-26 | -$551.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$128.00K derived: sum of 2 quarters · filed 2026-02-26 | -$223.00K derived: sum of 3 quarters · filed 2026-02-26 | -$315.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | -$57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$152.00K derived: sum of 2 quarters · filed 2024-11-13 | -$244.00K 10-Q · filed 2024-11-13 | -$328.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$95.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$187.00K 10-Q · filed 2024-08-08 | -$271.00K derived: sum of 3 quarters · filed 2024-08-08 | -$371.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$92.00K 10-Q · filed 2024-05-09 | -$176.00K derived: sum of 2 quarters · filed 2024-05-09 | -$276.00K derived: sum of 3 quarters · filed 2024-05-09 | -$379.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$84.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | -$184.00K derived: sum of 2 quarters · filed 2024-03-08 | -$287.00K derived: sum of 3 quarters · filed 2024-03-08 | -$361.00K 10-K · filed 2024-03-08 |
| 2022-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2023-11-17 | -$203.00K derived: sum of 2 quarters · filed 2023-11-17 | -$277.00K 10-Q · filed 2023-11-17 | |
| 2022-06-30 | -$103.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2023-11-17 | -$177.00K 10-Q/A · filed 2023-11-17 | ||
| 2022-03-31 | -$74.00K 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |